Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence

Cited by (1,006)

Items 601–700 of 1,006

1. Heart Failure in Atrial Fibrillation ― An Update on Clinical and Echocardiographic Implications ―
   Naoki Taniguchi, Yoko Miyasaka, Yoshinobu Suwa, Shoko Harada, Eri Nakai, Ichiro Shiojima · 2020 · Circulation Journal
2. Watch-PAT is Useful in the Diagnosis of Sleep Apnea in Patients with Atrial Fibrillation
   Riva Tauman, Murray J Berall, Richard Barnett Berry, Tamar Etzioni, Noam Shrater, Dennis Hwang, Ibrahim Marai, Prasanth Manthena, Anil Natesan Rama, Rebecca Spiegel et al. · 2020 · Nature and Science of Sleep
3. Relationship Between Adiponectin and Left Atrium Size in Uncomplicated Obese Patients: Adiponectin, a Link Between Fat and Heart
   Juan Ybarra, Eugenia Resmini, Francesc Planas, Francesc Navarro-López, Susan M. Webb, José María Pou, Alicia Santos Vives, Carlos Ballesta‐López · 2009 · Obesity Surgery
4. Epidemiología de la fibrilación auricular en España en los últimos 20 años
   Julián Pérez‐Villacastín, Nicasio Pérez‐Castellano, Javier Moreno · 2013 · Revista Española de Cardiología
5. Epidemiology and Economic Burden of Atrial Fibrillation
   Abhay Bajpai, A. John Camm, Irina Savelieva · 2007 · US Cardiology Review
6. Detection of Atrial Fibrillation After Surgical Ablation: Conventional Versus Continuous Monitoring
   Ralph J. Damiano, Christopher P. Lawrance, Lindsey L. Saint, Matthew C. Henn, Laurie A. Sinn, Jane T. Kruse, Marye J. Gleva, Hersh S. Maniar, Patrick M. McCarthy, Richard Lee · 2015 · The Annals of Thoracic Surgery
7. Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target
   Dobromir Dobrev · 2009 · Naunyn-Schmiedeberg s Archives of Pharmacology
8. New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation
   Yousif Ahmad, Gregory Y.H. Lip, Stavros Z. Apostolakis · 2012 · Expert Review of Cardiovascular Therapy
9. Prevalence and associating factors of atrial fibrillation in patients with hypertension: a nation-wide study
   Rungroj Krittayaphong, Ram Rangsin, Bandit Thinkhamrop, Cameron Paul Hurst, Suthee Rattanamongkolgul, Nintita Sripaiboonkij, Ahthit Yindeengam · 2016 · BMC Cardiovascular Disorders
10. Radiofrequency Catheter Ablation Improves the Quality of Life Measured with a Short Form-36 Questionnaire in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis
    Yun Gi Kim, Jaemin Shim, Jong‐Il Choi, Young‐Hoon Kim · 2016 · PLoS ONE
11. The burden of proof: The current state of atrial fibrillation prevention and treatment trials
    Rosita Zakeri, David R. Van Wagoner, Hugh G Calkins, Tom Wong, Heather Ross, Edwin Kevin Heist, Timothy E. Meyer, Peter Russell Kowey, Robert John Mentz, John G.F. Cleland et al. · 2017 · Heart Rhythm
12. Adherence to Rivaroxaban Compared with Other Oral Anticoagulant Agents Among Patients with Nonvalvular Atrial Fibrillation
    Colleen A. McHorney, Veronica Ashton, François Laliberté, Guillaume Germain, Willy Wynant, Concetta Crivera, Jeffrey R Schein, Patrick Lefèbvre, Eric David Peterson · 2017 · Journal of Managed Care & Specialty Pharmacy
13. Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report
    Stefano Fumagalli, Salah AM Said, Cécile Laroche, Debbie Gabbai, Serena Boni, Niccolò Marchionni, Giuseppe Boriani, Aldo Pietro Maggioni, Agata Musialik-Lydka, Adam Sokal et al. · 2017 · European Heart Journal - Cardiovascular Pharmacotherapy
14. Clinical and Economic Implications of AF Related Stroke.
    Ali Ali, Ahmed H. Abdelhafiz · 2016 · PubMed Central
15. GARFIELD-AF: A Worldwide Prospective Registry of Patients With Atrial Fibrillation at Risk of Stroke
    Jean‐Pierre Bassand, Patricia N Apenteng, Dan Atar, A. John Camm, Frank J.S. Cools, Ramon L. Corbalan, David Andrew Fitzmaurice, Keith A.A. Fox, Shinya Goto, Sylvia K. Haas et al. · 2020 · Future Cardiology
16. Atrial Fibrillation in End‐Stage Renal Disease
    Panagiotis G. Korantzopoulos, Stelios Kokkoris, Tong Liu, Ioannis D. Protopsaltis, Guangping Li, John A. Goudevenos · 2007 · Pacing and Clinical Electrophysiology
17. What are the costs of atrial fibrillation?
    Blomstrom Lundqvist, C., Lip, G. Y. H., Kirchhof, P. · 2011 · Europace
18. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population
    Jens Cosedis Nielsen, Yenn‐Jiang Lin, Márcio Jansen de Oliveira Figueiredo, Alireza Sepehri Shamloo, Alberto Alfie, Serge Bovéda, Nikolaos Dagres, Darío Di Toro, Lee L. Eckhardt, Kenneth A. Ellenbogen et al. · 2020 · Heart Rhythm
19. Advances in stroke prevention
    Ayesha Z. Sherzai, Mitchell S.V. Elkind · 2015 · Annals of the New York Academy of Sciences
20. Epidemiology of Atrial Fibrillation in Spain in the Past 20 Years
    Julián Pérez‐Villacastín, Nicasio Pérez‐Castellano, Javier Moreno · 2013 · Revista Española de Cardiología (English Edition)
21. Percutaneous Epicardial Left Atrial Appendage Closure: Intermediate-Term Results
    Charles J. Bruce, Christopher Stanton, Samuel J. Asirvatham, Andrew J. Danielsen, Susan B. Johnson, Douglas L. Packer, Paul A. Friedman · 2010 · Journal of Cardiovascular Electrophysiology
22. Synthesis of a highly water-soluble acacetin prodrug for treating experimental atrial fibrillation in beagle dogs
    Hui Liu, Yajing Wang, Lei Yang, Mei Ling Zhou, Man‐Wen Jin, Guo-Sheng Xiao, Yan Wang, Hai‐Ying Sun, Gui‐Rong Li · 2016 · Scientific Reports
23. Diminished PRRX1 Expression Is Associated With Increased Risk of Atrial Fibrillation and Shortening of the Cardiac Action Potential
    Nathan R. Tucker, Elena V. Dolmatova, Honghuang Lin, Rebecca R. Cooper, Jiangchuan Ye, William J. Hucker, Heather S. Jameson, Victoria A. Parsons, Lu-Chen C Weng, Robert W. Mills et al. · 2017 · Circulation Cardiovascular Genetics
24. Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR
    David Massicotte‐Azarniouch, John Paul Kuwornu, Juan Jesús Carrero, Ngan N. Lam, Amber O. Molnar, Deborah Lynn Zimmerman, Megan K. McCallum, Amit X. Garg, Manish M. Sood · 2017 · American Journal of Kidney Diseases
25. Association Between Blood Lipid Profiles and Atrial Fibrillation: A Case-Control Study
    Zhizhao Li, Xin Du, Xueyuan Guo, Ribo Tang, Chao Jiang, Nian Liu, Sanshuai Chang, Ronghui Yu, Deyong Long, Rong Bai et al. · 2018 · Medical Science Monitor
26. Epidemiology of atrial fibrillation in patients with cirrhosis and clinical significance: a meta-analysis
    Ronpichai Chokesuwattanaskul, Charat Thongprayoon, Tarun Jacob Bathini, O.A. O’Corragain, Konika Sharma, Somchai Prechawat, Karn Wijarnpreecha, Paul Thomas Kröner, Patompong Ungprasert, Wisit Cheungpasitporn · 2018 · European Journal of Gastroenterology & Hepatology
27. A review of the epidemiology of atrial fibrillation in sub‐Saharan Africa
    Jean Jacques Noubiap, Ulrich Flore Nyaga · 2019 · Journal of Cardiovascular Electrophysiology
28. Treatment of atrial fibrillation
    Abhay Bajpai, Irina Savelieva, A. John Camm · 2008 · British Medical Bulletin
29. Effects of metoprolol therapy on cardiac gap junction remodelling and conduction in human chronic atrial fibrillation
    Stefan Dhein, S Rothe, A Busch, D Rojas Gomez, Andreas Boldt, A Reutemann, Thomas Seidel, A. Salameh, Bettina Pfannmüller, A. J. Rastan et al. · 2011 · British Journal of Pharmacology
30. Atrial fibrillation and heart failure in the elderly
    Pedram Kazemian, Gavin Y. Oudit, Bodh I. Jugdutt · 2011 · Heart Failure Reviews
31. Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study
    Solveig Horstmann, Timolaos Rizos, Michael Lauseker, Markus Alfred Möhlenbruch, Ekkehart Jenetzky, Werner Hacke, Th. Steiner, Roland C. Veltkamp · 2013 · Journal of Neurology
32. Quality of life in older people with atrial fibrillation
    Deirdre A. Lane, Gregory Y.H. Lip · 2008 · Journal of Interventional Cardiac Electrophysiology
33. Mitochondrial Hyperfusion during Oxidative Stress Is Coupled to a Dysregulation in Calcium Handling within a C2C12 Cell Model
    Calum J. Redpath, Maroun Bou Khalil, Gregory Drozdzal, Milica Radisic, Heidi May McBride · 2013 · PLoS ONE
34. Renal denervation: effects on atrial electrophysiology and arrhythmias
    Dominik Linz, Arne van Hunnik, Christian Ukena, Sebastian Ewen, Felix Mahfoud, Stephan Henrik Schirmer, Matthias Lenski, Hans‐Ruprecht Neuberger, Ulrich Schotten, Michael Böhm · 2014 · Clinical Research in Cardiology
35. Effect of Spironolactone on Patients With Atrial Fibrillation and Structural Heart Disease
    Ryan S. Williams, James A. deLemos, Vassilis Dimas, JOAN S. REISCH, Joseph A. Hill, R. Haris Naseem · 2011 · Clinical Cardiology
36. The epidemiology of atrial fibrillation in adults depends on locale of diagnosis
    Roopinder Kaur Sandhu, Jeffrey Alexander Bakal, Justin Adrian Ezekowitz, Finlay Aleck McAlister · 2011 · American Heart Journal
37. Atrial fibrillation in Indigenous and non-Indigenous Australians: a cross-sectional study
    Christopher X J Wong, Anthony G. Brooks, Yi-Han Cheng, Dennis H. Lau, Geetanjali Rangnekar, Kurt C. Roberts‐Thomson, Jonathan M. Kalman, Alex D. H. Brown, Prashanthan Sanders · 2014 · BMJ Open
38. Radiofrequency ablation of accessory pathways in patients with the Wolff-Parkinson-White syndrome: the long-term mortality and risk of atrial fibrillation
    Rune Borregaard, P. Lukac, Christian Gerdes, D. Moller, Peter Thomas Mortensen, Lars Henning Pedersen, Jens Cosedis Nielsen, Henrik Kjærulf Jensen · 2014 · EP Europace
39. Incidence, Mortality, and Sex Differences of Non‐Valvular Atrial Fibrillation: A Population‐Based Study
    Christel Renoux, Valérie Patenaude, Samy Suissa · 2014 · Journal of the American Heart Association
40. National Utilization Patterns of Warfarin Use in Older Patients with Atrial Fibrillation: A Population-Based Study of Medicare Part D Beneficiaries
    Mukaila A. Raji, Matthew Lowery, Yu‐Li Lin, Yong‐Fang Kuo, Jacques Baillargeon, James S. Goodwin · 2013 · Annals of Pharmacotherapy
41. Meeting the Unmet Needs in Anticoagulant Therapy
    Jeffrey Ian Weitz · 2010 · European Journal Of Haematology
42. Pericardial fat volume and incident atrial fibrillation in the Multi‐Ethnic Study of Atherosclerosis and Jackson Heart Study
    Susan R. Heckbert, Kerri L. Wiggins, Chad T. Blackshear, Yi Yang, Jingzhong Ding, Jiankang Liu, Barbara McKnight, Álvaro Alonso, Thomas R. Austin, Emelia J. Benjamin et al. · 2017 · Obesity
43. Association between serum uric acid and atrial fibrillation: a cross-sectional community-based study in China
    Yue Chen, Yunlong Xia, Xu Han, Yiheng Yang, Xiaomeng Yin, Jing Qiu, Henghui Liu, Yong Zhou, Ying Liu · 2017 · BMJ Open
44. Central sleep apnea and atrial fibrillation: A review on pathophysiological mechanisms and therapeutic implications
    Alexandra M. Sanchez, Robin Elizabeth Germany, Matthew R. Lozier, Michael D. Schweitzer, Semaan Georges Kosseifi, Rishi G. Anand · 2020 · IJC Heart & Vasculature
45. Active esophageal cooling for the prevention of thermal injury during atrial fibrillation ablation: a randomized controlled pilot study
    Cory M. Tschabrunn, Sara Attalla, Jonathan A. Salas, David S. Frankel, Matthew Craig Hyman, Emily P. Simon, Tiffany Sharkoski, David J. Callans, Gregory E. Supple, Saman Nazarian et al. · 2021 · Journal of Interventional Cardiac Electrophysiology
46. Obesity and atrial fibrillation
    Hany S. Abed, Gary Wittert · 2013 · Obesity Reviews
47. Use of Warfarin in Elderly Patients With Non-Valvular Atrial Fibrillation – Subanalysis of the J-RHYTHM Registry –
    Eitaro Kodani, Hirotsugu Atarashi, Hiroshi Inoue, Ken Okumura, Takeshi Yamashita, Hideki Origasa, on behalf of the J-RHYTHM Registry Investigators · 2015 · Circulation Journal
48. Cost-effectiveness of cryoballoon ablation for the management of paroxysmal atrial fibrillation
    Matthew R. Reynolds, Mark Lamotte, DERICK M. TODD, Yaariv Khaykin, Simon Eggington, Stelios I. Tsintzos, Gunnar G. Klein · 2014 · EP Europace
49. Systems biology and cardiac arrhythmias
    Andrew A. Grace, Dan M. Roden · 2012 · The Lancet
50. Warfarin Use and Stroke Risk Among Patients With Nonvalvular Atrial Fibrillation in a Large Managed Care Population
    Steven Bruce Deitelzweig, Erin K. Buysman, Brett W. Pinsky, Michael Lacey, Yonghua Jing, Daniel Wiederkehr, John Graham · 2013 · Clinical Therapeutics
51. Vitamin D deficiency and atrial fibrillation
    Joseph Thompson, Rynda Nitiahpapand, Prashan Bhatti, Antonios Kourliouros · 2015 · International Journal of Cardiology
52. Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation
    Mehmet Akkaya, Koji Higuchi, Matthias Koopmann, Nathan S. Burgon, Ercan Erdoğan, K. Damal, Eugene G. Kholmovski, Christopher J. McGann, Nassir F. Marrouche · 2013 · EP Europace
53. Atrial fibrillation and arterial hypertension: A common duet with dangerous consequences where the renin angiotensin-aldosterone system plays an important role
    Teresa Maria Seccia, Brasilina Caroccia, María Lorenza Muiesan, Gian Paolo Rossi · 2016 · International Journal of Cardiology
54. Underuse of anticoagulation in patients with atrial fibrillation
    Ajay Vallakati, William R. Lewis · 2015 · Postgraduate Medicine
55. Efficacy and safety of driver‐guided catheter ablation for atrial fibrillation: A systematic review and meta‐analysis
    Francisco Daniel Ramirez, David H. Birnie, Girish M. Nair, Agnieszka Szczotka, Calum J. Redpath, Mouhannad M. Sadek, Pablo B. Nery · 2017 · Journal of Cardiovascular Electrophysiology
56. Atrial fibrosis in non–atrial fibrillation individuals and prediction of atrial fibrillation by use of late gadolinium enhancement magnetic resonance imaging
    Johannes Siebermair, Promporn Suksaranjit, Christopher J. McGann, Kathryn A. Peterson, Mobin Kheirkhahan, Alex A. Baher, Kavitha Damal, Reza Wakili, NASSIR F. MARROUCHE, Brent D. Wilson · 2019 · Journal of Cardiovascular Electrophysiology
57. Dronedarone: A New Antiarrhythmic Agent
    Ola O. Oyetayo, Carrie E. Rogers, Prudence O. Hofmann · 2010 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
58. Frequent Periodic Leg Movement During Sleep Is an Unrecognized Risk Factor for Progression of Atrial Fibrillation
    Mahek Mirza, Win-Kuang Shen, Aamir A. Sofi, Canh Tran, Ahad Jahangir, Sulaiman Sultan, Uzma Khan, Viqar Maria, Chi Cho, Arshad Jahangir · 2013 · PLoS ONE
59. The Burden of Atrial Fibrillation and Other Cardiac Arrhythmias in an Employed Population: Associated Costs, Absences, and Objective Productivity Loss
    Nicholas J. Rohrbacker, Nathan L. Kleinman, Sarah White, Jamie L. March, Matthew R. Reynolds · 2010 · Journal of Occupational and Environmental Medicine
60. Stroke Prophylaxis in Atrial Fibrillation: Searching for Management Improvement Opportunities in the Emergency Department: The HERMES-AF Study
    Blanca Coll‐Vinent, Alfonso Martı́n, Francisco Malagón, Coral Suero, Juan Sánchez, Mercedes Varona, Manuel Cancio, Susana Sánchez, Eugeni Montull, Carmen del Arco et al. · 2014 · Annals of Emergency Medicine
61. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion.
    Bernhard Meier, Yuri Blaauw, Ahmed Khattab, Torsten Lewalter, Horst Sievert, Claudio Tondo, Michael Glikson · 2015 · PubMed
62. Whole Exome Sequencing in Atrial Fibrillation
    Steven A. Lubitz, Jennifer A. Brody, Nathan A. Bihlmeyer, Carolina Roselli, Lu-Chen C Weng, Ingrid Elisabeth Christophersen, Álvaro Alonso, Eric Boerwinkle, Richard A. Gibbs, Joshua C. Bis et al. · 2016 · PLoS Genetics
63. Feasibility of intracardiac echocardiography imaging from the left superior pulmonary vein for left atrial appendage occlusion
    Do Young Kim, Seung Yong Shin, Jin Seok Kim, Seong Hwan Kim, Young‐Hoon Kim, Hong Euy Lim · 2018 · International journal of cardiac imaging
64. Symptoms In Atrial Fibrillation: A Contemporary Review And Future Directions.
    Steven Thomas Heidt, Anna Louise Kratz, Kayvan Najarian, Afton L. Hassett, Hakan Oral, Richard Gonzalez, Brahmajee K. Nallamothu, Daniel Joseph Clauw, Hamid Ghanbari · 2016 · PubMed Central
65. Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice
    Alberto Corsini, Nicola Ferri, Marco Proietti, Giuseppe Boriani · 2020 · Drugs
66. QT prolongation in patients with index evaluation for seizure or epilepsy is predictive of all-cause mortality
    C. Anwar A. Chahal, Joseph A. Gottwald, Erik K. St. Louis, Jiang Xie, Peter A. Brady, Rabe E. Alhurani, Paul C. Timm, Prabin Bikram Thapa, Jay N. Mandrekar, Elson L. So et al. · 2021 · Heart Rhythm
67. The blanking period after atrial fibrillation ablation: an European Heart Rhythm Association survey on contemporary definition and management
    Stefano Bordignon, Sérgio Barra, Rui Andre Providencia, Carlo de Asmundis, Éloi Marijon, Michał M. Farkowski, Ante Anić, María José Guerra Palmero, Jędrzej Kosiuk, Konstantinos E. Iliodromitis et al. · 2022 · EP Europace
68. Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study
    Christian Torp-Pedersen, Harry J.G.M. Crijns, C. Gaudin, Richard L. Page, Stuart J. Connolly, S. H. Hohnloser, for the ATHENA Investigators · 2011 · EP Europace
69. Economic Burden and Disparities in Healthcare Resource Use Among Adult Patients with Cardiac Arrhythmia
    Derek H. Tang, Adrienne M. Gilligan, Klaus Romero · 2013 · Applied Health Economics and Health Policy
70. New Anticoagulants for Atrial Fibrillation
    Magdalena Sobieraj‐Teague, Martin James O'Donnell, John W. Eikelboom · 2009 · Seminars in Thrombosis and Hemostasis
71. Association Between Panic Disorder and Risk of Atrial Fibrillation
    Ya-Fen Cheng, Hsin‐Bang Leu, Ching‐Chieh Su, Chin‐Chou Huang, Chia-Hung Chiang, Po‐Hsun Huang, Chia‐Min Chung, Shing‐Jong Lin, Jaw‐Wen Chen, Wan‐Leong Chan · 2012 · Psychosomatic Medicine
72. Importance of Physical Fitness on Predictive Effect of Body Mass Index and Weight Gain on Incident Atrial Fibrillation in Healthy Middle-Age Men
    Irene Grundvold, Per Torger Skretteberg, Knut Liestøl, Knut Gjesdal, Gunnar Erikssen, Sverre Erik Kjeldsen, Harald Arnesen, Jan Emil Erikssen, Johan Bodegård · 2012 · The American Journal of Cardiology
73. Impact of hospitalization on health-related quality of life in atrial fibrillation patients in Canada and the United States: Results from an observational registry
    Matthew R. Reynolds, Edith Morais, PETER J. ZIMETBAUM · 2010 · American Heart Journal
74. Atrial Fibrillation in Patients Undergoing Liver Transplantation—A Single-Center Experience
    Andrea Vannucci, R Rathor, Neeta A. Vachharajani, W. Chapman, Ivan M. Kangrga · 2014 · Transplantation Proceedings
75. Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke
    Kui Kai Lau, Pak‐Hei Chan, Kai‐Hang Yiu, Yap‐Hang Chan, Shasha Liu, Koon‐Ho Chan, Chun‐Yip Yeung, Sheung-Wai Li, Hung‐Fat Tse, Chung‐Wah Siu · 2014 · Cardiology Journal
76. ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: indications, patient selection, staff skills, organisation, and training
    Gavino Casu, Michele Massimo Gulizia, Giulio Molon, Patrizio Mazzone, Andrea Audo, Giancarlo Casolo, Emilio Di Lorenzo, Michele Portoghese, Christian Pristipino, Renato Pietro Ricci et al. · 2017 · European Heart Journal Supplements
77. Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: Rationale and design of the ELDERCARE-AF study
    Ken Okumura, Gregory Y.H. Lip, Masaharu Akao, Kimihiko Tanizawa, Masayuki Fukuzawa, Kenji Abe, Masahiro Akishita, Takeshi Yamashita · 2017 · American Heart Journal
78. Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016
    Mohammad‐Ali Jazayeri, Venkat Lakshmi Kishan Vuddanda, Mohit K. Turagam, Valay K. Parikh, Madhav Lavu, Donita Atkins, Matthew Earnest, Luigi Di Biase, Andrea Natale, David J. Wilber et al. · 2017 · Journal of Cardiovascular Electrophysiology
79. The management of atrial fibrillation: An integrated team approach – insights of the 2016 European Society of Cardiology guidelines for the management of atrial fibrillation for nurses and allied health professionals
    Jeroen Hendriks, Hein Heidbüchel · 2018 · European Journal of Cardiovascular Nursing
80. Impact of ageing on presentation and outcome of mitral regurgitation due to flail leaflet: a multicentre international study
    Jean-François Aviérinos, Christophe Michel Tribouilloy, Francesco Grigioni, Rakesh M. Suri, Andréa Barbieri, Héctor I. Michelena, Teresa Ionico, Dan Ruşinaru, Sébastien Ansaldi, Gilbert Habib et al. · 2013 · European Heart Journal
81. Efficacy and safety of oral anticoagulation in elderly patients with atrial fibrillation
    Ilaria Cavallari · 2018 · The Anatolian Journal of Cardiology
82. The Role Of Renin Angiotensin System In Atrial Fibrillation.
    Girish M. Nair, Pablo B. Nery, Calum J. Redpath, David H. Birnie · 2014 · PubMed Central
83. The burden of atrial fibrillation in the Netherlands
    Harald E. Heemstra, Robby Nieuwlaat, M. Meijboom, Harry J.G.M. Crijns · 2011 · Netherlands Heart Journal
84. Long Sleep Duration Is an Independent Risk Factor for Incident Atrial Fibrillation in a Chinese Population: A Prospective Cohort Study
    Qiaofeng Song, Xiaoxue Liu, Wanning Hu, Wenhua Zhou, Aijuan Liu, Xizhu Wang, Shouling Wu · 2017 · Scientific Reports
85. Impact of Atrial Fibrillation During ST-Segment–Elevation Myocardial Infarction on Infarct Characteristics and Prognosis
    Sebastian J. Reinstadler, Thomas Stiermaier, Charlotte Eitel, Georg Friedrich Fuernau, Mohammed F. Saad, Janine Pöss, Suzanne de Waha, Meinhard Mende, Steffen Desch, Bernhard Metzler et al. · 2018 · Circulation Cardiovascular Imaging
86. Oral Anticoagulation in Chronic Kidney Disease and Atrial Fibrillation
    Gunnar Henrik Heine, Vincent Mathias Brandenburg, Stephan Henrik Schirmer · 2018 · Deutsches Ärzteblatt international
87. The Impact of New and Emerging Clinical Data on Treatment Strategies for Atrial Fibrillation
    Eric N. Prystowsky, A. John Camm, Gregory Y.H. Lip, Maurits A. Allessie, Jean‐François Bergmann, GÜNTER E. BREITHARDT, Josép Brugada, Harry J.G.M. Crijns, Patrick T. Ellinor, Daniel B. Mark et al. · 2010 · Journal of Cardiovascular Electrophysiology
88. The Influence of Stroke Risk Factors and Comorbidities on Assessment of Stroke Therapies in Humans and Animals
    Sandeep Ankolekar, Sarah S. J. Rewell, David William Howells, Philip M. Bath · 2012 · International Journal of Stroke
89. Surgery for atrial fibrillation
    Richard Lee, Jane T. Kruse, Patrick M. McCarthy · 2009 · Nature Reviews Cardiology
90. Transcription factors and atrial fibrillation
    Saagar Mahida · 2013 · Cardiovascular Research
91. Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants
    Charalampos Kasmeridis, Stavros Z. Apostolakis, Lars Holger Ehlers, Lars Hvilsted Rasmussen, Giuseppe Boriani, Gregory Y.H. Lip · 2013 · PharmacoEconomics
92. Frequent Early Cardiac Complications Contribute to Worse Stroke Outcome in Atrial Fibrillation
    Hans T.H. Tu, Bruce C.V. Campbell, Leonid P. Churilov, Jonathan M. Kalman, Kennedy R. Lees, Patrick D. Lyden, Ashfaq M Shuaib, Geoffrey Alan Donnan, Stephen M. Davis, on behalf of the VISTA collaborators · 2011 · Cerebrovascular Diseases
93. Atrial fibrillation, arrhythmia burden and thrombogenesis
    Chee Wah Khoo, Suresh Krishnamoorthy, Hoong Sern Lim, Gregory Y.H. Lip · 2011 · International Journal of Cardiology
94. Incidence and predictors of atrial fibrillation and its impact on long-term survival in patients with supraventricular arrhythmias
    Cevher Özcan, Jordan B. Strom, John B. Newell, MOUSSA C. MANSOUR, Jeremy Neil Ruskin · 2014 · EP Europace
95. Preoperative atrial fibrillation is an independent risk factor for mid-term mortality after concomitant aortic valve replacement and coronary artery bypass graft surgery
    Akshat Saxena, Diem T. Dinh, Jim Dimitriou, Christopher Michael Reid, Julian Anderson Smith, Gilbert C. Shardey, Andrew E. Newcomb · 2013 · Interactive Cardiovascular and Thoracic Surgery
96. Atrial fibrillation and sleep-disordered breathing.
    Florent Lavergne, Laurent Morin, Jeff P. Armitstead, Adam Benjafield, Glenn N. Richards, Holger Woehrle · 2015 · PubMed Central
97. A Magnetic-Resonance-Imaging-Compatible Remote Catheter Navigation System
    M. Ali Tavallaei, Yogesh Thakur, S. Haider, Maria Drangova · 2012 · IEEE Transactions on Biomedical Engineering
98. Perspectives and challenges of antioxidant therapy for atrial fibrillation
    Iveta Gašparová, Peter Kubatka, Radka Opatřilová, Martin Čaprnda, Slavomíra Filipová, Luı́s Rodrigo, Leoné Malan, Ioana Monica Mozos, Miroslava Rabajdová, Vladimír Nosáľ et al. · 2016 · Naunyn-Schmiedeberg s Archives of Pharmacology
99. Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation – A Nationwide Cohort Study
    Tze‐Fan Chao, Chia‐Jen Liu, Ta‐Chuan Tuan, Su‐Jung Chen, Tzeng‐Ji Chen, Gregory Y.H. Lip, Shih‐Ann Chen · 2017 · Scientific Reports
100. Atrial Fibrillation Epidemic and Hospitalizations
     Christopher X J Wong, Dennis H. Lau, Prashanthan Sanders · 2014 · Circulation